Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia

NCT00517881 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to the slow recruitment rate.

Conditions

Anemia

Interventions

DRUG: Methoxy polyethylene glycol-epoetin beta (C.E.R.A.)

Sponsor

Hoffmann-La Roche